Refractory Behçet's disease succesfully treated with Roflumilast.

Clinical and experimental dermatology(2023)

Cited 0|Views8
No score
Abstract
We report the first case of refractory Behçet disease with spectacular response to roflumilast 250 μg per day and no notable adverse effects beyond a self-resolving headache.
More
Translated text
Key words
behçet,disease
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined